Nazli Dizman Profile Banner
Nazli Dizman Profile
Nazli Dizman

@NazliDizman

Followers
8,594
Following
5,763
Media
413
Statuses
17,841
Explore trending content on Musk Viewer
@NazliDizman
Nazli Dizman
2 years
🥁Thrilled to announce that our paper is out @NatureMedicine ! We looked at the impact of nivolumab/ipilimumab +/- #CBM588 a bifidogenic live bacterial product, on gut #Microbiome , serum cytokines & clinical outcomes in #mRCC 🙏🙏 @montypal @LuisMezaco @PauloBergerot et al. 1/n🧵
Tweet media one
77
187
868
@NazliDizman
Nazli Dizman
2 years
🥳Thrilled to share that I'm going to @MDAndersonNews for Heme/Onc fellowship!! Forever grateful for my family, #BestMentorEver @montypal , many mentors/sponsors & friends who supported me along the way🙏 Can't wait to become an official member of the #Oncology community!
Tweet media one
107
23
740
@NazliDizman
Nazli Dizman
4 years
Thrilled to share that I am starting my residency training @YaleIMed 🥳🥳 Huge thanks to best leader, teacher & mentor ever @montypal for giving me a chance 3yrs ago & continuously supporting me along the way to my dreams #WomenInMedicine #HeForShe #IMG #MedTwitter @cityofhope
Tweet media one
Tweet media two
Tweet media three
Tweet media four
42
14
297
@NazliDizman
Nazli Dizman
2 years
Incredibly honored to receive @KidneyCancer Trailblazer Award🙏 Thankful for mentorship & support of Drs. #PatrickPirrotte #HarrietKluger @MarkDSiegel1 @YaleIMed while taking our research a step further & many other mentors/collaborators along the way who made this possible!
Tweet media one
@KidneyCancer
Kidney Cancer
2 years
⭐️Congratulations to KCA Trailblazer Award winner @NazliDizman @YaleCancer @YaleMed ! She will study the impact of CBM588 on metabolomic profile in patients with mRCC. #RCC #kidneycancer
Tweet media one
4
8
60
33
23
243
@NazliDizman
Nazli Dizman
2 years
Starting 2023 with another powerful PD note by @MarkDSiegel1 celebrating open doors, diversity, and opportunities for all! "Since 2011, the year I became PD, we’ve matched IMGs from 🇮🇳🇮🇷🇮🇱🇸🇦🇹🇷🇬🇷🇮🇹🇦🇹🇩🇪🇩🇰🇷🇺🇨🇴🇵🇪🇧🇷🇲🇽🇨🇦. This year, we’re trying for more." 👉
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
38
217
@NazliDizman
Nazli Dizman
1 year
It’s the most wonderful time of the year 🥰 #ASCO23 @ASCO Can’t wait to connect with brilliant minds and dive into the latest breakthroughs in #Oncology ! @OncoAlert @IMG_Oncologists @montypal @NarjustFlorezMD @DrChoueiri @fumikochino @IshwariaMD @VivekSubbiah @neerajaiims
Tweet media one
12
14
185
@NazliDizman
Nazli Dizman
1 year
Our hearts are shattered. The scale of tragedy unfolding in #Turkey & #Syria after the #earthquake is unimaginable. Thousands in affected regions need help for rescue now & recovery in the months to come. For donations: Pls share🙏
4
70
163
@NazliDizman
Nazli Dizman
1 year
Thrilled to be among this excellent list of @ASCO #GU23 featured voices! Can’t wait to experience another amazing #GU23 , witness groundbreaking science & build new friendships & collaborations 😇 @OncoAlert @montypal @DrChoueiri @tompowles1 @Florez_Lab @PavlosMsaouel @OncHahn
@ASCO
ASCO
1 year
🎉 Announcing the #GU23 Featured Voices! Follow along for expert insights & join the discussion leading up to and during the Symposium. ⬇️ @neerajaiims   @RCCadvocate   @crisbergerot   @NazliDizman   @ShuchiGulati   @sophia_kamran   @DrRanaMcKay   @wandering_gu   @DrKarineTawagi
Tweet media one
0
14
95
16
10
161
@NazliDizman
Nazli Dizman
7 months
Tweet media one
Tweet media two
Tweet media three
12
33
139
@NazliDizman
Nazli Dizman
2 years
I often recall the day I emailed @montypal for a research position in 🇺🇸 as an IM resident in 🇹🇷 in '16 & his reply in 6 min! With his mentorship/sponsorship. I had opportunities I could've never imagined Elections open! #VoteASCO #VoteMonty , amazing advocate for pts & trainees!
Tweet media one
Tweet media two
Tweet media three
@montypal
Sumanta K. Pal, MD, FASCO
2 years
2 of the best days of my career were (1) when @NazliDizman matched at @YaleIMed & (2) yesterday when she matched at @MDAndersonNews . W mentorship from @JenWargoMD @PavlosMsaouel #Tannir & the amazing folks at #MDACC , sky is the limit. Congrats to my "daughter"! (Picture c2017)
Tweet media one
7
16
204
2
14
139
@NazliDizman
Nazli Dizman
2 years
Feels AMAZING to see my name with @AnaVManana @NarjustDumaMD @TheLancetOncol . #DumaLab 🥳🥁 I'm filled with gratitude!! 🙏🙏 I was blessed to be a mentee of @NarjustDumaMD who values her mentees' opinions and provides endless support and guidance. Thanks for all you do!!
@NarjustFlorezMD
Narjust Florez, MD, FASCO
2 years
"Both the primary predictor and the clinical outcome (ie, overall survival) tested bear great potential to be affected by social factors" by @NazliDizman & @AnaVManana Check out this letter to the editor @TheLancetOncol ! #DumaLab
Tweet media one
5
18
86
5
12
129
@NazliDizman
Nazli Dizman
1 year
Million thanks to @ASCO for creating a space for #IMG in #oncology ! There is a lot to do to identify and overcome challenges specific to IMGs. Visa issues, residency/fellowship selection process, grantsmanship, mentor/sponsor search and more. IMGs, allies, mentors and mentees,
Tweet media one
@IMG_Oncologists
IMG Oncologists
1 year
🚨Save the date🚨 June 2nd, 4-6 PM CST, Room S103, McCormick Place We are super excited to announce the launch of the @ASCO #IMG Community of Practice this upcoming #ASCO23 . Join our all-star speakers to discuss barriers & opportunities for IMGs in #oncology . @ASCOPost
Tweet media one
8
63
195
4
31
121
@NazliDizman
Nazli Dizman
5 years
Humbled to receive #ASCO2019 @ConquerCancerFd merit award with the great mentor @montypal !! Cordially thankful for having the most wonderful mentor, leader, teacher @montypal and fantastic colleagues @crisbergerot @PauloBergerot @hsuperjo88 @cityofhope
@montypal
Sumanta K. Pal, MD, FASCO
5 years
If you don’t know this face already, you will soon - @NazliDizman will have a huge impact in oncology. So proud of my @cityofhope fellow who received a @ConquerCancerFd Merit Award. W @PauloBergerot & @crisbergerot getting awards in past years, it’s the the ultimate trifecta!
Tweet media one
5
12
101
17
11
120
@NazliDizman
Nazli Dizman
10 months
Tweet media one
@ASCO
ASCO
10 months
👋 Hey, GU cancer researchers! Don’t miss your chance to share your research with the largest multidisciplinary global audience for GU cancer research. Submit your #GU24 abstract by tomorrow, 9/26: @ASTRO_org   @UroOnc   @wandering_gu
1
13
34
4
16
119
@NazliDizman
Nazli Dizman
1 year
@ASCO International Medical Graduates @IMG Community of Practice meeting was absolutely awe-inspiring. It was an immense honor to be a part of this remarkable effort !!! #ASCO23 @IMG_Oncologists @DrChoueiri @ZiadBakouny 🙏👏A million thanks to our esteemed speakers & audience
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@DrChoueiri
Toni Choueiri, MD
1 year
Tweet media one
4
30
90
2
27
111
@NazliDizman
Nazli Dizman
1 year
While the pubs of prospective efforts with IO-based combinations in further line treatment of #mRCC are around the corner, we appreciate the opportunity to publish our retrospective experience with #pembrolizumab #axitinib in ≥ 2nd line. 🙏Thanks @YaleIMed @YaleCancer , for
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@YaleIMed
Yale Internal Medicine
1 year
A new study by @NazliDizman demonstrates promising efficacy using #pembrolizumab and #axitinib as further line treatment for metastatic renal cell carcinoma. Read more: @YaleMed #MedTwitter
Tweet media one
0
2
16
5
20
104
@NazliDizman
Nazli Dizman
4 years
Great presentation by Dr. Padmanee Sharma of @MDAndersonNews @AACR #AACR20 on why PD-1 and PD-L1 inhibitors performed poorly in #mCRPC to date and what the next steps should be
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
40
104
@NazliDizman
Nazli Dizman
4 years
Thrilled to present our work as an oral presentation at #SITC2020 ! Huge thanks to #bestmentor @montypal 🙏 🥁 #MedTwitter #AcademicTwitter Join our session on the development of a novel therapeutic for immune checkpoint inhibitor colitis! @sitcancer #WomenInMedicine @jitcancer
Tweet media one
Tweet media two
@sitcancer
Society for Immunotherapy of Cancer
4 years
Gain early access to #SITC2020 and complete your registration by Oct. 26. You’ll have the opportunity to establish your profile, visit exhibitors and network in the Connection Lounge two weeks ahead of SITC 2020. REGISTER TODAY:
Tweet media one
0
2
4
18
15
102
@NazliDizman
Nazli Dizman
3 years
‼️ Please stop scrolling down and check out this study @ASCO #ASCO21 @OncoAlert #DumaLab #onctwitter ‼️ Crucial and very timely observation by @IshwariaMD @DrSGraff @DrMarkham & @HemOncWomenDocs et al. Heartfelt thanks to all authors for your dedication and leadership!!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
38
100
@NazliDizman
Nazli Dizman
2 years
🥁🥳Wonderful to be among #GU22 @ASCO @ConquerCancerFd merit award recipients and be part of the #BestMentorEver @montypal 's "family" with the rising stars @ZeynepZengin @LuisMezaco @ChawlaNeal @nsayeghmd ! Can't wait for @ASCO #GU22 to finally see many other friends and mentors!
@montypal
Sumanta K. Pal, MD, FASCO
2 years
So proud of my "kids" at @cityofhope ( @LuisMezaco @NazliDizman @ZeynepZengin @ChawlaNeal ) for getting @ASCO Merit Awards for #GU22 ! Lots of great folks on this list including my "nephew" @nsayeghmd who works w my "brother" @neerajaiims at @huntsmancancer . #workfamily = #family
Tweet media one
20
24
136
9
12
99
@NazliDizman
Nazli Dizman
3 years
So incredibly honored to be selected as an @OncoAlert rising star! I cordially thank @montypal for his endless support and mentorship and the @OncoAlert team, especially @weoncologists , for this once in a lifetime opportunity 🙏🙏
@OncoAlert
OncoAlert
3 years
Dear Friends, An honor to introduce OncoAlert's Newest Rising Star⭐️Dr @NazliDizman of @cityofhope & @YaleIMed ⚕️ Dr. Dizman is doing amazing research in #GUOncology under the guidance of her mentor & our @OncoAlert 🚨 colleague @montypal Kudos Dr. Dizman‼️
5
16
81
6
5
94
@NazliDizman
Nazli Dizman
2 years
🥳🥁Truly honored to be an @ASCO #GU22 featured voice with this amazing group of GU #oncology leaders! Tune in #OncTwitter #MedTwitter ! @ASCO #GU22 starts 2/17 AM! Program 👉 @ConquerCancerFd @OncoAlert @CancerDotNet @HemOncWomenDocs @HemOncFellows
@ASCO
ASCO
2 years
🎉 Announcing the #GU22 Featured Voices! Follow along for expert insights & join the discussion ⬇️ @neerajaiims   @crisbergerot   @PauloBergerot   @NazliDizman   @pre_rad   @kidneycan   @CaPsurvivorship @ERPlimackMD   @KidneyCancerDoc   @DrKarineTawagi
Tweet media one
2
31
115
7
11
92
@NazliDizman
Nazli Dizman
4 years
As always, @mattsydes amazed the audience today @ASCO #GU20 with a great 20-minute presentation on clinical impact/relevance and statistical significance/certainty with many must-read references!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
31
92
@NazliDizman
Nazli Dizman
1 year
Here is the day #1 of @ASCO #GU23 !! Full of excitement for innovative science, seeing many of my favorite people and establishing new friends and collaborations! @montypal @neerajaiims @PGrivasMDPhD @Uromigos @DrChoueiri @TiansterZhang @oncoalert @OncBrothers @DrRanaMcKay
Tweet media one
1
11
93
@NazliDizman
Nazli Dizman
1 year
Reviewing @ASCO resources in prep for #ASCO23 , I became amazed by the thoughtfully curated program for #Trainee & #EarlyCareer Oncologists which is simply a whole another conference in and of itself. Kudos to #TECAG 👏 👉 @OncoAlert #OncTwitter #MedTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
33
92
@NazliDizman
Nazli Dizman
1 year
Beautiful views during our train ride from #London to #Edinburgh for #IKCSEU23 ! Perfect way to practice my presentation without looking at my laptop screen 😅😎 @KidneyCancer community, looking forward to seeing you soon! @OncoAlert @MichaelStaehler @BradLeibovichMD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@KidneyCancer
Kidney Cancer
1 year
Welcome to everyone attending 2023 IKCS: Europe in Edinburgh, kicking off tomorrow! We're so pleased you are joining us for an amazing #kidneycancer program. Be sure to use #IKCSEU23 to follow the discussion from wherever you are!
Tweet media one
0
7
36
3
7
92
@NazliDizman
Nazli Dizman
4 years
🥁 Huge congrats to @montypal for his #ArtiHurria clinical teacher of the year award @cityofhope 👏👏 Thanks for being a great teacher, mentor, and a strong advocate for us! Very well deserved 👏👏 @crisbergerot @PauloBergerot @NickSalgia @ZeynepZengin @LuisMezaco @arafflemd
Tweet media one
12
11
89
@NazliDizman
Nazli Dizman
6 months
🥁 Next up! #GU24 rockstar @AmandaNizamMD @ClevelandClinic with outcomes with #enfortumab #EV s/p platinum based chemo + maintenance #avelumab ! 👏🙌 Kudos to @AmandaNizamMD and all #UNITE investigators 👏 @koshkin85 @ShuchiGulati @OAlhalabiMD @MDAndersonNews @OncoAlert
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
35
86
@NazliDizman
Nazli Dizman
1 year
Tweet media one
@montypal
Sumanta K. Pal, MD, FASCO
2 years
Tx @drenriquegrande ! I was nervous. @Eminem said "U've only got 1 shot!" & that's true for the @myESMO Prez sesh; didn't want to disappoint @peters_solange @FAndreMD @CharlesSwanton & #ESMO22 audience. I'm no authority on the discussant role but heres my tips 4 trainees; plz add!
Tweet media one
23
111
412
2
24
87
@NazliDizman
Nazli Dizman
6 months
Thanks so much @DrChoueiri , @TDorffOnc , and @DrRanaMcKay and all @ASCO #GU24 @OncLive fellows forum participants for insightful comments 🙏 🙏 Truly grateful for being a part of @montypal @CityofHope_GU @gregcaporaso @TGen team and witnessing transition of microbiome-directed
@DrChoueiri
Toni Choueiri, MD
6 months
⭐️ @NazliDizman taking the stage by storm while discussing outcomes in Nivo+Ipi with vs without CBM588 in mRCC @OncLive @montypal @DrRanaMcKay @CParkMD @Silke_Gillessen @OncBrothers @TDorffOnc
Tweet media one
2
20
76
11
14
86
@NazliDizman
Nazli Dizman
2 years
Convinced my @YaleIMed co-resident and the winner of the most innovative #MedTwitter #Halloween costume @SwathiK_MD to create a Twitter account 😊 Yes, she is WebMD 🤣🙊
Tweet media one
4
7
85
@NazliDizman
Nazli Dizman
1 month
🙈 😅 Thanks so much @montypal . I'll always need your steady hand, both in my career and for hanging posters! 😂 Honored to present another work from our team. 🙏 @EbrahimiHedyeh @ReginaBarCar @CityofHope_GU @arafflemd @PauloBergerot @crisbergerot
@montypal
Sumanta K. Pal, MD, FASCO
1 month
So true! @NazliDizman is a star. When she first came to @cityofhope , I always knew she would be my boss one day. Now, after residency at @YaleIMed & fellowship at @MDAndersonNews , I suppose that day has come … 📸 below is me putting up her #ASCO24 poster.
Tweet media one
9
22
136
1
9
83
@NazliDizman
Nazli Dizman
2 years
🥁It's #Residency #Match2023 application time!! ❔Getting similar Qs from applicants on how to organize their #ERAS CV, esp posters/abstracts I summarized my approach here. There is probably no right or wrong answer. Appreciate comments! @IMG_Oncologists #IMG #MedEd #MedTwitter
Tweet media one
Tweet media two
Tweet media three
4
29
79
@NazliDizman
Nazli Dizman
2 years
Such an exciting day!! Huge congrats to @ASCO president elect #DrRobinZon , board members @dapattmd #DrJenniferTemel and #DrKathleenMoore and nominating committee @NehaVapiwala and #BestMentorEver @montypal !!!
Tweet media one
Tweet media two
Tweet media three
3
13
78
@NazliDizman
Nazli Dizman
4 years
Such a great feeling to contribute to this @NatRevNeph review article on RCC genomics w #bestmentorever @montypal @cityofhope & E.Philip 👇 Pls check out 👇 We detailed the current value of individual #genomic alterations & gene signatures in #RCC #kidneycancer subtypes
Tweet media one
Tweet media two
Tweet media three
@NatRevNeph
Nature Reviews Nephrology
4 years
New Review online! @montypal , @NazliDizman and Errol J. Philip discuss the prognostic and predictive value of #genomics in #RCC .
Tweet media one
0
11
39
6
22
78
@NazliDizman
Nazli Dizman
2 years
📢Check out our poster at @ASCO #GU22 - L6! 💡We present the evolution of metabolic pathways w nivolumab/ipilimumab +/- CBM588 and with respect to response to treatment response in pts with #mRCC . @OncoAlert @montypal @LuisMezaco @PauloBergerot @TGen @CityofHope_GU @urotoday
Tweet media one
1
17
76
@NazliDizman
Nazli Dizman
3 years
Thrilled to be an @ASCO #GU21 featured voice among the experts of the field @TiansterZhang , @ZiadBakouny and @DrSpratticus !! Can’t wait for tomorrow!!
@ASCO
ASCO
3 years
The GU Cancers Symposium starts tomorrow! Follow our Featured Voices and join the discussion using #GU21 📲 @ZiadBakouny   @NazliDizman   @DrSpratticus   @TiansterZhang
Tweet media one
0
14
70
3
14
72
@NazliDizman
Nazli Dizman
3 years
PhII Nivo+Cabo in IO-naive #nccRCC by @ChungHanLee3 @MVossMD @motzermd @sloan_kettering et al. @ASCO #ASCO21 Abstract #4509 n=40 w/ pRCC, unclassified RCC, translocation RCC ✅PFS: 12.5 m ✅OS: 28 m ✅ORR:47.5% (5/6 pts w NF2 mut+ tm & 4/5 w/ FH mut+ tms) ✅DCR:97.5% @OncoAlert
Tweet media one
1
38
72
@NazliDizman
Nazli Dizman
1 year
Such a fun night as we near the end of #ASCO23 🥰 @PGrivasMDPhD ’s Greek dinner is definitely one of the must-attend sessions every @ASCO 😁 Love the new tradition of combining it with the birthday celebration of @CharuAggarwalMD & @montypal ! 🎂🥳🎈 @OncoAlert
Tweet media one
Tweet media two
@TiansterZhang
Tian Zhang, MD, MHS
1 year
Happy birthday to @CharuAggarwalMD @montypal — two amazing friends, at Greek dinner that @PGrivasMDPhD hosts with all friends!! What a great way to wrap up @ASCO Monday. #ASCO23 @OncoAlert
3
8
60
3
9
73
@NazliDizman
Nazli Dizman
4 years
It was a pleasure to publish @NatRevNeph with @montypal @ejphilip on #Genomics of #RCC
@NatRevNeph
Nature Reviews Nephrology
4 years
In this Review, @montypal , @NazliDizman and Errol J. Philip provide a comprehensive overview of the prognostic and predictive value of genomics in renal cell carcinoma. Currently free to access. #RCC
Tweet media one
0
26
63
4
14
73
@NazliDizman
Nazli Dizman
2 years
🙏🙏 Truly inspiring @YaleIMed #GrandRounds by the one and only @DrEricWiner @YaleSOM @YaleCancer “There is almost always room for hope because science marches forward” #MedEs #MedTwitter #OncTwitter @OncoAlert @SmilowCancer @YaleIM_Chiefs @YaleHemOnc
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
19
71
@NazliDizman
Nazli Dizman
3 years
👏Kudos @TRMcFar and @neerajaiims @Huntsman_GU @huntsmancancer !! Impressive work @ASCO #GU21 suggesting BRCA mutation as an early event in disease evolution, and offering a rationale for earlier use of #PARPinhs in #mCRPC . @OncoAlert #prostatecancer #AcademicChatter
Tweet media one
2
30
71
@NazliDizman
Nazli Dizman
4 months
Humbled and grateful for the nomination in the NextGen Disruptors category alongside incredible superstars @KekoaMDPhD , @AnaVManana , @loveandmedicine , @NiuSanford , @LymphClinician !! Many thanks to @HemOncToday @GoHealio , the selection committee, nominators, along with my mentors,
@HemOncToday
HemOnc Today
4 months
These NextGen Disruptor nominees are sure to continue making their own path toward improving care: @KekoaMDPhD @AnaVManana @loveandmedicine @NiuSanford @NazliDizman @LymphClinician Pick the next big thing with your votes: And join us June 1 in Chicago!
0
11
41
2
16
70
@NazliDizman
Nazli Dizman
6 months
🥁Kicking off @ASCO #GU24 one day early with an excellent line up of faculty and fellows at @Onclive fellows forum! ✨Looking forward to learning more about everyone’s research and journey, and connecting with visionaries in the field @DrChoueiri @DrRanaMcKay @OncBrothers
Tweet media one
Tweet media two
Tweet media three
1
18
70
@NazliDizman
Nazli Dizman
3 years
Honored to be selected to attend @AACR Molecular Biology in Clinical Oncology Workshop. Can't wait to learn from the giants of cancer research @rosslevinemd @kaelin_lab @KimrynRathmell @JenWargoMD & develop our project on metatranscriptomics of gut microbiome in #RCC 🙏 @montypal
Tweet media one
Tweet media two
@AmyABaran
Amy A. Baran
3 years
Physician-scientists/clinical fellows: apply now for the @AACR Molecular Biology in Clinical Oncology Workshop! For over 25 years this workshop has trained this critical cohort of the cancer workforce! Apps due May 11. #doubledocs #physicianscientists
1
10
24
9
9
70
@NazliDizman
Nazli Dizman
4 years
🙏Thanks so much @YaleIMed for featuring our study on gut microbiome modulation via probiotics in metastatic renal cell carcinoma pts on targeted therapies as one of the @YaleMedicine Discoveries & Impact articles 🥳 @YaleHemOnc @YaleIM_Chiefs 🙏 @montypal @PauloBergerot et al.
Tweet media one
4
10
68
@NazliDizman
Nazli Dizman
1 month
Indeed, we had an absolutely fantastic time filled with reflection, inspiration, and discussions on future directions at #ASCO24 IMG CoP meeting! A huge thank you to our presenters, panelists, over 200 attendees, many volunteers, and @ASCO for their support! Can't wait for
Tweet media one
@ZiadBakouny
Ziad Bakouny, MD, MSc
1 month
What an incredible @ASCO IMG Community of Practice session it was! Thanks to all the speakers and everyone who joined. Looking forward to #ASCO25 already! #ASCO24 @NazliDizman @DrChoueiri @KarunNeupaneMD @LeiDeng3 @neerajaiims @GIcancerDoc @NarjustFlorezMD @montypal
Tweet media one
Tweet media two
0
23
61
0
28
68
@NazliDizman
Nazli Dizman
2 years
Kicking off #IKCSNA22 at @PeerView panel with an excellent discussion on adjuvant #RCC treatment by @montypal @TiansterZhang #DavidMcDermott !
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
20
66
@NazliDizman
Nazli Dizman
1 year
🔸Check out @Chrislabaki ’s poster board G6 @ASCO #GU23 ⬇️ORR, TTF, OS in #Chromophobe #RCC w IO based first-line combinations compared to ccRCC ✅Need for further work on molecular determinants of poor outcomes in ChRCC @OncoAlert @IMDConline @Florez_Lab @DrChoueiri @montypal
Tweet media one
0
17
65
@NazliDizman
Nazli Dizman
3 years
🥳I was today years old when I learned how to highlight all abbreviations in #MicrosoftWord @office @Microsoft 👉What tips and tricks do you know? #AcademicTwitter #MedEd #MedTwitter #womeninstem #OncTwitter #WomenInMedicine
Tweet media one
4
20
62
@NazliDizman
Nazli Dizman
4 years
@kisacakimdir Bilim ve tıp alanında başarılı olmada birbirimize destek olup yol göstererek beraber yükselmenin önemi çok büyük. Bu amaca hizmetleri için @kisacakimdir ‘e sonsuz teşekkürler. İletişime geçmek isteyen arkadaşlar, bana twitter’dan ulaşabilirsiniz.
1
0
59
@NazliDizman
Nazli Dizman
3 years
👏 POUT 49.2 mos f/u @ASCO #GU21 by @AlisonBirtle @JimCatto @tompowles1 @EmmaHall71 et al. n=261 UTUC pT2-T4 & pN0-3 or N+ Adjuvant Plt/gem vs surveillance 🔶DFS: 63% vs 46%, HR:0.51 p=0.0006 🔶OS: 65% vs 57%, p=0.09 @OncoAlert @ecancer @montypal @neerajaiims #MedEd #UroOnc
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
32
62
@NazliDizman
Nazli Dizman
1 month
You are so kind @MichaelLaPelusa , really grateful for your friendship 🙏 I’d call it “ @ASCO ” effect 😇 So many brilliant trainees and insightful and supportive oncologists at #ASCO24 looking forward to connecting with each other 👏👏 PS: Congrats @MichaelLaPelusa and
@MichaelLaPelusa
Michael LaPelusa, MD
1 month
The “ @NazliDizman ” effect: every time you run into her at @ASCO #ASCO24 , you are guaranteed to be pleasantly interrupted by (and introduced to) at least one new superstar acquaintance. Grateful to be her co-fellow! @MDAndersonNews
Tweet media one
1
6
58
0
14
61
@NazliDizman
Nazli Dizman
2 years
Happy holidays and new year everyone🙏🥳 🥂 To the family we're born with and to the family we make along the way! #Higgins #TedLasso 😉
Tweet media one
3
5
61
@NazliDizman
Nazli Dizman
4 years
Day 10 of @pfizer @BioNTech_Group vaccine dose #1 . Such a relief to know that I’ll be walking on the beautiful red straight line from now on 🥳 #MaskUp #VaccinesWork #VaccinesSaveLives 🙏🏻 @YaleIMed @YaleIM_Chiefs @YNHH @cityofhope
Tweet media one
0
10
60
@NazliDizman
Nazli Dizman
3 years
💫Less than 2 weeks until @ASCO #GU21 !! Very excited for witnessing the groundbreaking science, improving outcomes and separating Kaplan-Mayer curves🧡 Tbh, I am so glad this year is online. I can't wait to see friends and mentors at #GU22 in SF! @montypal @CityofHope_GU
Tweet media one
1
14
59
@NazliDizman
Nazli Dizman
2 months
🥁 Mark your calendars for the @ASCO #IMG Community of Practice Meeting and join us in room S103 on 5/31 between 4-6 pm. #ASCO24 ✨Can't wait to connect, hear from amazing guests, and foster new collaborations! @ZiadBakouny @DrChoueiri @MDAndersonNews @MSKCancerCenter
@IMG_Oncologists
IMG Oncologists
2 months
🚨Save the date🚨 ⏰May 31st, 4-6 PM CST 📍Room S103, McCormick Place We are super excited to announce the 2nd annual meeting of the @ASCO #IMG Community of Practice this upcoming #ASCO24 🌟 Join our all-star speakers to discuss barriers & opportunities for IMGs in #oncology !
Tweet media one
2
33
81
3
15
58
@NazliDizman
Nazli Dizman
3 months
Excited to announce! 🎉 Mark your calendars for the @ASCO #IMG Community of Practice Meeting at #ASCO24 🕰️Fri 5/31, 4-6 PM CST at Room S103 McCormick Place. Looking forward to coming together to celebrate IMGs and discuss ways to support each other. Join us! @ZiadBakouny
@IMG_Oncologists
IMG Oncologists
3 months
🚨Save the date 🚨 @ASCO International Medical Graduates Community of Practice Meeting ⏰May 31st, 4-6 PM CST 📌Room S103, McCormick Place Join us to discuss barriers & opportunities for IMGs in #oncology ASCO IMG CoP 👉 @ASCOPost #IMG #MedEd #MedTwitter
Tweet media one
8
35
59
2
23
57
@NazliDizman
Nazli Dizman
4 years
@marklewismd
Mark Lewis, MD, FASCO
4 years
Tweet media one
49
80
1K
1
2
56
@NazliDizman
Nazli Dizman
1 year
Tweet media one
@ASCO
ASCO
1 year
🚨 #ASCO23 abstracts are now available! Late-Breaking Abstracts (LBAs) will be released at 7:00 AM CT on the day of scientific presentation at the meeting. Explore this year's research ➡️ #OncTwitter
Tweet media one
1
45
115
1
12
55
@NazliDizman
Nazli Dizman
4 years
🙏Thanks so much, @OncoAlert for selecting me as a rising star🙏A great honor to be recognized by @Oncoalert that inspires me & many other trainees around the🌍 🙏It's not possible for me to show my thankfulness in words to the #BestMentorEver @montypal for his endless support 👏
Tweet media one
@OncoAlert
OncoAlert
4 years
A special treat for #SABCS20 The @OncoAlert 🚨Network proudly announces our4⃣th Rising Star⭐️ Our Warmest Congratulations to @NazliDizman 👩‍⚕️of @YaleMedicine & @cityofhope who was nominated by her mentor @montypal for her outstanding research on GU #Cancers Best @weoncologists
Tweet media one
18
15
65
2
3
54
@NazliDizman
Nazli Dizman
1 year
📢Beautiful work by @BariShahlaMD et al #ASCO23 suggesting that microbial metabolites of tryptophan, indoles, bear immunosuppressive properties & could drive resistance to #Immunotherapy in #RCC . @ASCO @ConquerCancerFd #Microbiome @OncoAlert @MoffittNews #KCSM @urotoday
Tweet media one
Tweet media two
Tweet media three
0
18
53
@NazliDizman
Nazli Dizman
9 months
📣📣 Kicking off #LEAD2023 with the co-chairs @AnaVManana @rachnatshroff with great excitement! Amazing agenda today 🌟Negotiation skills building 🌟Empowerment through social media 🌟Mentorship/sponsorship @DrJulieVose @JulieBrahmer @drteplinsky @DrSGraff @NarjustFlorezMD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
13
55
@NazliDizman
Nazli Dizman
9 months
🎉🙌🎖️So proud of you my dear friend @AmandaNizamMD ; you inspire me everyday! 👏Dear #MedTwitter #OncTwitter , take a moment to appreciate the collaborative and supportive atmosphere captured in this video and the smiles on the faces of leaders in #GU #oncology as they support
6
6
54
@NazliDizman
Nazli Dizman
4 years
📢Excellent presentation by Dr. Arlene Siefke-Radtke @MDAndersonNews on the complex topic of biomarkers in #UrothelialCarcinoma @ASCO #ASCO20 Best biomarker for IO=>Response PD-L1 & FGFR =>Used but limitations still exist & further work needed 👉
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
17
54
@NazliDizman
Nazli Dizman
3 years
Such a great pleasure to meet and learn #RCC management from @montypal @TiansterZhang Dr. #NizarTannir in person again! Thanks to #IKCS2021 & @PeerView 🙏 👉Attaching a few of their many important slides here for #MedTwitter #OncTwitter community @CityofHope_GU
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
19
54
@NazliDizman
Nazli Dizman
3 years
👏👏 @DrMHofman @Prof_IanD @ANZUPtrials @ASCO #GU21 & simultaneous pub @TheLancet #LuPSMA vs #cabazitaxel #mCRPC s/p docetaxel n=200 pts w/ high PSMA-expression LuPSMA: ⬆️PFS @ 1y 19% vs 3%, HR 0.63 ⬆️ORR 49% vs 24% ⬇️Gr 3-4 AEs, Fatigue ⬆️Functioning
Tweet media one
Tweet media two
0
33
53
@NazliDizman
Nazli Dizman
11 months
With your permission, @DrChoueiri , I plan on framing a printout of this tweet for my future office wall🙏😎 Your guidance and support over the years have been invaluable. We're incredibly fortunate to have you as a role model and I can't thank @montypal & @ASCO enough for
@DrChoueiri
Toni Choueiri, MD
1 year
Superstar, team player, hard worker, creator, dependable and just an amazing human being ….few words to describe @NazliDizman and more cc: @montypal @NarjustFlorezMD
1
9
78
1
4
53
@NazliDizman
Nazli Dizman
2 years
This is the tweet that made me burst into tears! Can't thank @montypal enough for giving me a chance to follow my dreams 6 years ago and changing my life forever! 🙏🙏🙏 #IMG #WomenInMedicine
@montypal
Sumanta K. Pal, MD, FASCO
2 years
So proud of @NazliDizman . This photo dates back to 2016, when she had just arrived from #Turkey . @manuelmaiamd had joined from #Brazil . @hsuperjo88 & I thought an @Angels game would be a good intro to #SoCal . Had no idea this would be the start of a lifetime friendship! (15/25)
Tweet media one
1
2
25
0
1
52
@NazliDizman
Nazli Dizman
1 month
Bright and early at @ASCO #ASCO24 today 🌅. Had a fantastic breakfast with the amazing @NarjustFlorezMD 🙏 Truly grateful to have you to turn to for advice 🙏 Thanks for the incredible insights! @Florez_Lab
@NarjustFlorezMD
Narjust Florez, MD, FASCO
1 month
NO BETTER WAY TO START THE DAY! Mentorship meeting with the unstoppable Dr. @NazliDizman - career paths, grants and work-life integration. Our mentees should learn from our mistake and grow at a faster pace than we have. #ASCO24
Tweet media one
0
8
47
0
4
52
@NazliDizman
Nazli Dizman
2 years
📢Check out our paper reporting mortality outcomes with respect to development of AKI during treatment w #immunotherapy @YaleCancer @YaleNephrology 🙏So grateful to be part of this amazing effort led by @meganlebaker @dmoledina @fperrywilson #DrHarrietKluger et al. @OncoAlert
@dmoledina
Dennis Moledina, MD PhD
2 years
Pleased to share our study showing that while acute kidney injury (AKI) in patients on immune checkpoint inhibitors (ICI) associates with higher mortality, the mortality of AKI from acute interstitial nephritis (AIN) is not higher. 1/
1
18
49
2
9
52
@NazliDizman
Nazli Dizman
4 years
🧐Reviewing tips of @ASCOPost on how to use social media @ASCO #ASCO20 to maximize virtual meeting experience 🔊Experts of #SoMe , any other recommendations? @montypal @DrChoueiri @PauloBergerot @crisbergerot @neerajaiims @tmprowell @ShikhaJainMD @GlopesMd
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
24
50
@NazliDizman
Nazli Dizman
2 years
Tweet media one
@IMG_Oncologists
IMG Oncologists
2 years
❔Did you know #InternationalMedicalGraduates comprise 44.5% of #Hematology #Oncology fellows and 33.5% of #Hematologist #Oncologists ? 🗺️We are here to connect #IMGs and allies, and enhance networking and mentorship opportunities for all! Follow us for more!
Tweet media one
9
37
184
2
17
51
@NazliDizman
Nazli Dizman
1 year
Huge congrats to my dear friends and colleagues @ZeynepZengin and @LuisMezaco for this fantastic achievement with the exemplary leadership and mentorship of #BestMentorEver @montypal 🎊🎉👏 IMHO, there is no better place to train than @YaleIMed , and I can't wait for these two to
@montypal
Sumanta K. Pal, MD, FASCO
1 year
Words cannot express how proud I am of my @cityofhope fellows @ZeynepZengin 🇹🇷 & @LuisMezaco 🇵🇪, who matched at @YaleIMed just moments ago (yes, I am wearing a #YaleDad hat!). Their hard work & dedication over 3y has paid off. Huge thanks to @NazliDizman for blazing this trail &
Tweet media one
36
42
277
2
2
51
@NazliDizman
Nazli Dizman
3 years
💡Post-hoc analysis of subgroups in #CheckMate9ER by @apolo_andrea @tompowles1 @motzermd & @DrChoueiri et al @ASCO #ASCO21 Cabo/Nivo:⬆️PFS ⬆️ORR >sunitinib regardless of baseline ✅ @IMDConline risk ✅Met sites (liver, bone, or lung) ✅# met sites ✅Disease burden @OncoAlert
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
22
50
@NazliDizman
Nazli Dizman
4 years
👏👏Phenomenal and must-watch presentation by @CaPsurvivorship on sequencing available therapies in #mCSPC @ASCO #ASCO20 @NorthwesternU 📢Check out #MedEd #MedTwitter #PCSM #ProstateCancer #WomenInMedicine
Tweet media one
Tweet media two
Tweet media three
3
29
50
@NazliDizman
Nazli Dizman
1 year
🌟👏🎉Huge congratulations to @Montypal @CityofHope_GU ! Totally agree with @neerajaiims ; @Montypal 's dedication and contribution to cancer research, exceptional mentorship and leadership within @ASCO deserve a long applause! 🙌 #ASC23 #MedTwitter #OncTwitter #MedEd @Urotoday
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 year
@Montypal never tires of highlighting and praising others’ work but rarely talks about his own accomplishments👉 THREE back-to-back FIRST author @TheLancet papers on original research in the last 3 yrs (2021, 2022, 2023). 👇👇👇Congrats Monty for being such a humble and generous
Tweet media one
Tweet media two
Tweet media three
5
37
144
1
6
49
@NazliDizman
Nazli Dizman
2 years
Oh! Have I told you that I met @chadinabhan #HealthcareUnfiltered yesterday @ASCO #GU22 in person? 😎😎😎 @OncoAlert
Tweet media one
3
0
50
@NazliDizman
Nazli Dizman
2 years
Words can not express how grateful I'm for @montypal @COHMedOnc for giving me a chance while looking for research opportunities in US 🇺🇸 as an IM resident from #Turkey 🇹🇷 in 2016, & mentoring/supporting & inspiring me w his passion for cancer research for years. @IMG_Oncologists
@montypal
Sumanta K. Pal, MD, FASCO
2 years
Fellowship programs: @NazliDizman @YaleIMed is applying this year! You will never meet a harder working, more driven individual. Thank you @KidneyCancer for offering her this amazing opportunity to further her research goals!
6
14
106
0
5
50
@NazliDizman
Nazli Dizman
1 year
Grateful to have been part of @SWOG #DrNickVogelzang #microbiome in #GU cancers symposium with insightful discussions on awe-inspiring research paving the way for novel microbiome-based interventions. 👏 @montypal #MichaelLiss 🙏 for contributions of all panelist and audience
Tweet media one
1
11
49
@NazliDizman
Nazli Dizman
2 months
📌Attention #ASCO24 goers, #students #trainees ! 👉Make sure to check out this thoughtfully written guide by @IvyLorena_Md @Jessica_Aduwo @CamilaBragancaX @ASCO ! ⭐️Especially love the quote "Don’t be shy, find the people you want to meet and introduce yourself, select the
@IvyLorena_Md
Ivy Riano, M.D.
2 months
Dear Students, Trainees, and Early-Career Oncologists, We put together these tips to advice on how to plan your ASCO annual meeting! ⭐️ Grow professionally and have fun! @ASCO @ASCOTECAG @ASCOPres @jacobadashek @cissamathias #ASCOConnection
Tweet media one
7
39
117
0
18
46
@NazliDizman
Nazli Dizman
4 years
📢Just out!! @EUplatinum Bev/Atezo vs sunitinib in #mRCC w/ #sarcomatoid features 👏👏 @brian_rini @motzermd @Uromigos @tompowles1 @UgoDeGiorgi @drenriquegrande 👉Overall PFS 8.3 vs 5.3 mo, HR:52 👉PD-L1+ PFS 8.6 vs 5.6 mo, HR 0.45 👉ORR 49% vs 14%
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
25
49
@NazliDizman
Nazli Dizman
2 years
👏Excellent work by @TalalZarif1 @DanaFarber_GU suggesting an association between albumin trends, ECOG PS and overall survival w enfortumab vedotin in #mUC @ASCO #GU22 !! @IrbazRiaz @adib_elio @BradMcG04 @DrChoueiri @sonpavde @OncoAlert @urotoday @ASCOPost
Tweet media one
3
10
49
@NazliDizman
Nazli Dizman
10 months
🎉🎊 Awesome news!! Congratulations @montypal 👏 Looking forward to the amazing impact you’ll make in this new role. @cityofhope is extremely lucky to have you 👏👏 @ASCO @CityofHope_GU @cityofhopeoc @MOASC_Office @crisbergerot @ZeynepZengin @arafflemd @AlexisLevee
@montypal
Sumanta K. Pal, MD, FASCO
10 months
Excited to announce that I have taken on the role of Vice Chair of Academic Affairs in the Department of Medical Oncology & Experimental Therapeutics at @cityofhope . Candidly, in my 17 years at this great institution, I’ve been reluctant to take on roles in leadership. Why?
152
46
678
2
9
49
@NazliDizman
Nazli Dizman
2 years
🙏Huge thanks to our patients who made this study possible. I feel truly honored and grateful to have worked on this project with #BestMentor @montypal & amazing co-first authors @LuisMezaco @PauloBergerot &collaborators @TGen @kortylmt lab, #Miyarisan pharma & all co-authors🙏
Tweet media one
7
7
48
@NazliDizman
Nazli Dizman
1 year
Unfortunately, visa-related issues are the root cause of many struggles @IMG_Oncologists come across. We got the answers from Susan Saliba, JD in our seminar where we discussed ways to tackle J1 waiver, EB1/2 application, visa denials, travel restrictions & more! Check out!
@IMG_Oncologists
IMG Oncologists
1 year
Could not agree more with @thenasheffect @FawziAbuRous @AminNassarMD @drsomedeb ! Visa-related issues are such a barrier to the careers of IMGs. We’ve uploaded our recent seminar on the topic below, hope you find it helpful. A lot more needs to be done!
0
6
20
1
11
49
@NazliDizman
Nazli Dizman
3 years
Ok @ASCO #ASCO21 , I think I need a break for the evening🙈 I almost misspelled "emotion" as "IMmotion" when I was texting @inas_md a few minutes ago. Is it normal? @montypal @NarjustDumaMD @crisbergerot @DrChoueiri @VivekSubbiah @AnaVManana @CityofHope_GU @marklewismd
6
9
47
@NazliDizman
Nazli Dizman
1 year
🚨 #InternalMedicine #Residency #programdirectors , be on the lookout for this exceptional candidate!! #Match24 👏👏 @ReneeSaliby never ceases to impress everyone with her exceptional work under the mentorship of @DrChoueiri @BraunMDPhD @DrRanaMcKay @LabSignoretti &
@DrChoueiri
Toni Choueiri, MD
1 year
And now ⁦ @ReneeSaliby ⁩ looking at circulating bio markers in non-clear cell RCC during #KCRS23 @kidneycan #RMS #Dana9fellows #WCRM @eddy_saad ⁩ ⁦ @marc_eid ⁩ ⁦ @KarlSemaan ⁩ ⁦ @BraunMDPhD ⁩ ⁦ @DrRanaMcKay #RMS
Tweet media one
0
20
56
2
15
47
@NazliDizman
Nazli Dizman
3 years
👏 👏 Check out this poster by @OncHahn , @ConquerCancerFd Merit Award winner @ASCO #GU21 ! ⬆️ Subcutaneous and visceral adiposity ⬆️Response to androgen signaling inhibitors in men with #mCRPC @MDAndersonNews @ChapinMD @Huntsman_GU #MedEd #OncTwitter #AcademicChatter #UroOnc
Tweet media one
@PavlosMsaouel
Pavlos Msaouel
3 years
Congratulations @OncHahn for receiving a #GU21 merit award. You make us all proud. @neerajaiims @PGrivasMDPhD @montypal
2
6
33
1
19
46
@NazliDizman
Nazli Dizman
1 year
Also found this 😎 Free professional headshots 📸 at #ASCO23 😇 👉 @ASCO @OncoAlert @HemOncFellows #OncTwitter #MedTwitter
Tweet media one
@NazliDizman
Nazli Dizman
1 year
Reviewing @ASCO resources in prep for #ASCO23 , I became amazed by the thoughtfully curated program for #Trainee & #EarlyCareer Oncologists which is simply a whole another conference in and of itself. Kudos to #TECAG 👏 👉 @OncoAlert #OncTwitter #MedTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
33
92
3
16
46
@NazliDizman
Nazli Dizman
1 month
Tweet media one
Tweet media two
@IMG_Oncologists
IMG Oncologists
2 months
🚨Save the date🚨 ⏰May 31st, 4-6 PM CST 📍Room S103, McCormick Place We are super excited to announce the 2nd annual meeting of the @ASCO #IMG Community of Practice this upcoming #ASCO24 🌟 Join our all-star speakers to discuss barriers & opportunities for IMGs in #oncology !
Tweet media one
2
33
81
1
16
45
@NazliDizman
Nazli Dizman
2 years
Thanks @acccancercenter @StenioZequi et al for the opportunity to present at #NextFrontiersToCureCancer ! Enjoyed discussing #microbime - #cancer axis & learning from @PrimoLaraMD @VincentWenxinXu @PBarataMD and many other experts in the field 🙏 @OncoAlert #OncTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@StenioZequi
Stenio Zequi
2 years
Today great talks from Samuel Denmade @brady_urology bipolar therapy, Pedro Barata from @Tulane ADT, PARP Inhibtors etc in M* Pca and @NazliDizman microbiota and kidney cancer, @PrimoLaraMD @acccancercenter Next Frontiers to Cure Cancer
1
4
16
2
11
45
@NazliDizman
Nazli Dizman
3 years
Dr. Arlene Siefker-Radtke @MDAndersonNews continues to amaze the audience with insightful interpretation of the enfortumab data @ASCO #GU21 ✅Enfortumab vedotin is here to stay as 3rd L #mUC tx w/ level 1 evidence ‼️ Side effects exist, monitor the caveats @OncoAlert
Tweet media one
Tweet media two
Tweet media three
1
15
44
@NazliDizman
Nazli Dizman
3 years
🔶KEYNOTE-365 @ASCO #GU21 by Dr. Leonard Joseph Appleman @UPMCHillmanCC 🔶Pembrolizumab+docetaxel in #mCRPC s/p abi/enza, n=104 PSA response (≥50%⬇️): 34% ORR: 23.1% rPFS: 8.5 mos OS: 20.2 mos 👉KN-921, doce vs doce/pembro underway! @OncoAlert @urotoday #ProstateCancer
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
24
45
@NazliDizman
Nazli Dizman
3 years
🥁ACIS trial - Oral abstract session @ASCO #GU21 by @DRathkopf et al 🔶 Apalutamide + abiraterone vs placebo + abiraterone n=982 chemo-naive mCRPC Apa+ Abi ⬆️rPFS 24 mo vs 16.6 mo ⬆️OS 36 mo vs 33 mo, p=0.498 Similar HRQL, slightly high AE rates
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
14
44
@NazliDizman
Nazli Dizman
3 years
👏👏IMvigor130 @MattGalsky @Prof_IanD @drenriquegrande @ASCO #GU21 Atezo vs Plt/gem/Placebo tx naive la/ #mUC 🔶All: Similar OS regardless of PD-L1 status 🔶Cis-ineligible PD-L1 IC0/1: Similar OS PD-L1 IC2/3:⬆️OS 18.5 vs10 mos HR:0.53 (0.30-0.94) & ⬆️ORR:38% vs 33% @OncoAlert
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
25
43
@NazliDizman
Nazli Dizman
8 months
I wholeheartedly agree with @NarjustFlorezMD ! @DrChoueiri is a genuine visionary, leaving an unparalleled impact on countless trainees and faculty in the field of #oncology worldwide! 🗳️ @ASCO elections are open! Vote for @DrChoueiri ! @OncoAlert @urotoday @VJHemOnc
@NarjustFlorezMD
Narjust Florez, MD, FASCO
8 months
Moving to @DanaFarberNews during a pandemic, after a Dx of thoracic outlet syndrome & in the middle of a divorce was challenging to say the least Dr. @DrChoueiri supported me to overcome these challenges & make DFCI my new home Vote for this leader at @ASCO election!
Tweet media one
1
21
115
0
14
44
@NazliDizman
Nazli Dizman
4 years
📢Hey, #SITC2020 ! Check out "Immunotherapy toxicities" session & our presentation on a novel therapeutic for immune checkpoint inhibitor colitis w @montypal @VivreonB @sitcancer @jitcancer #MedTwitter #AcademicChatter #AcademicTwitter #WomenInSTEM #WomenInMedicine #Immunotherapy
Tweet media one
@NazliDizman
Nazli Dizman
4 years
Thrilled to present our work as an oral presentation at #SITC2020 ! Huge thanks to #bestmentor @montypal 🙏 🥁 #MedTwitter #AcademicTwitter Join our session on the development of a novel therapeutic for immune checkpoint inhibitor colitis! @sitcancer #WomenInMedicine @jitcancer
Tweet media one
Tweet media two
18
15
102
4
15
43